Cargando…
Tissue distribution and elimination after oral and intravenous administration of different titanium dioxide nanoparticles in rats
OBJECTIVE: The aim of this study was to obtain kinetic data that can be used in human risk assessment of titanium dioxide nanomaterials. METHODS: Tissue distribution and blood kinetics of various titanium dioxide nanoparticles (NM-100, NM-101, NM-102, NM-103, and NM-104), which differ with respect t...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4105399/ https://www.ncbi.nlm.nih.gov/pubmed/24993397 http://dx.doi.org/10.1186/1743-8977-11-30 |
_version_ | 1782327358404952064 |
---|---|
author | Geraets, Liesbeth Oomen, Agnes G Krystek, Petra Jacobsen, Nicklas R Wallin, Håkan Laurentie, Michel Verharen, Henny W Brandon, Esther FA de Jong, Wim H |
author_facet | Geraets, Liesbeth Oomen, Agnes G Krystek, Petra Jacobsen, Nicklas R Wallin, Håkan Laurentie, Michel Verharen, Henny W Brandon, Esther FA de Jong, Wim H |
author_sort | Geraets, Liesbeth |
collection | PubMed |
description | OBJECTIVE: The aim of this study was to obtain kinetic data that can be used in human risk assessment of titanium dioxide nanomaterials. METHODS: Tissue distribution and blood kinetics of various titanium dioxide nanoparticles (NM-100, NM-101, NM-102, NM-103, and NM-104), which differ with respect to primary particle size, crystalline form and hydrophobicity, were investigated in rats up to 90 days post-exposure after oral and intravenous administration of a single or five repeated doses. RESULTS: For the oral study, liver, spleen and mesenteric lymph nodes were selected as target tissues for titanium (Ti) analysis. Ti-levels in liver and spleen were above the detection limit only in some rats. Titanium could be detected at low levels in mesenteric lymph nodes. These results indicate that some minor absorption occurs in the gastrointestinal tract, but to a very limited extent. Both after single and repeated intravenous (IV) exposure, titanium rapidly distributed from the systemic circulation to all tissues evaluated (i.e. liver, spleen, kidney, lung, heart, brain, thymus, reproductive organs). Liver was identified as the main target tissue, followed by spleen and lung. Total recovery (expressed as % of nominal dose) for all four tested nanomaterials measured 24 h after single or repeated exposure ranged from 64-95% or 59-108% for male or female animals, respectively. During the 90 days post-exposure period, some decrease in Ti-levels was observed (mainly for NM-100 and NM-102) with a maximum relative decrease of 26%. This was also confirmed by the results of the kinetic analysis which revealed that for each of the investigated tissues the half-lifes were considerable (range 28–650 days, depending on the TiO(2)-particle and tissue investigated). Minor differences in kinetic profile were observed between the various particles, though these could not be clearly related to differences in primary particle size or hydrophobicity. Some indications were observed for an effect of crystalline form (anatase vs. rutile) on total Ti recovery. CONCLUSION: Overall, the results of the present oral and IV study indicates very low oral bioavailability and slow tissue elimination. Limited uptake in combination with slow elimination might result in the long run in potential tissue accumulation. |
format | Online Article Text |
id | pubmed-4105399 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-41053992014-07-31 Tissue distribution and elimination after oral and intravenous administration of different titanium dioxide nanoparticles in rats Geraets, Liesbeth Oomen, Agnes G Krystek, Petra Jacobsen, Nicklas R Wallin, Håkan Laurentie, Michel Verharen, Henny W Brandon, Esther FA de Jong, Wim H Part Fibre Toxicol Research OBJECTIVE: The aim of this study was to obtain kinetic data that can be used in human risk assessment of titanium dioxide nanomaterials. METHODS: Tissue distribution and blood kinetics of various titanium dioxide nanoparticles (NM-100, NM-101, NM-102, NM-103, and NM-104), which differ with respect to primary particle size, crystalline form and hydrophobicity, were investigated in rats up to 90 days post-exposure after oral and intravenous administration of a single or five repeated doses. RESULTS: For the oral study, liver, spleen and mesenteric lymph nodes were selected as target tissues for titanium (Ti) analysis. Ti-levels in liver and spleen were above the detection limit only in some rats. Titanium could be detected at low levels in mesenteric lymph nodes. These results indicate that some minor absorption occurs in the gastrointestinal tract, but to a very limited extent. Both after single and repeated intravenous (IV) exposure, titanium rapidly distributed from the systemic circulation to all tissues evaluated (i.e. liver, spleen, kidney, lung, heart, brain, thymus, reproductive organs). Liver was identified as the main target tissue, followed by spleen and lung. Total recovery (expressed as % of nominal dose) for all four tested nanomaterials measured 24 h after single or repeated exposure ranged from 64-95% or 59-108% for male or female animals, respectively. During the 90 days post-exposure period, some decrease in Ti-levels was observed (mainly for NM-100 and NM-102) with a maximum relative decrease of 26%. This was also confirmed by the results of the kinetic analysis which revealed that for each of the investigated tissues the half-lifes were considerable (range 28–650 days, depending on the TiO(2)-particle and tissue investigated). Minor differences in kinetic profile were observed between the various particles, though these could not be clearly related to differences in primary particle size or hydrophobicity. Some indications were observed for an effect of crystalline form (anatase vs. rutile) on total Ti recovery. CONCLUSION: Overall, the results of the present oral and IV study indicates very low oral bioavailability and slow tissue elimination. Limited uptake in combination with slow elimination might result in the long run in potential tissue accumulation. BioMed Central 2014-07-03 /pmc/articles/PMC4105399/ /pubmed/24993397 http://dx.doi.org/10.1186/1743-8977-11-30 Text en Copyright © 2014 Geraets et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Geraets, Liesbeth Oomen, Agnes G Krystek, Petra Jacobsen, Nicklas R Wallin, Håkan Laurentie, Michel Verharen, Henny W Brandon, Esther FA de Jong, Wim H Tissue distribution and elimination after oral and intravenous administration of different titanium dioxide nanoparticles in rats |
title | Tissue distribution and elimination after oral and intravenous administration of different titanium dioxide nanoparticles in rats |
title_full | Tissue distribution and elimination after oral and intravenous administration of different titanium dioxide nanoparticles in rats |
title_fullStr | Tissue distribution and elimination after oral and intravenous administration of different titanium dioxide nanoparticles in rats |
title_full_unstemmed | Tissue distribution and elimination after oral and intravenous administration of different titanium dioxide nanoparticles in rats |
title_short | Tissue distribution and elimination after oral and intravenous administration of different titanium dioxide nanoparticles in rats |
title_sort | tissue distribution and elimination after oral and intravenous administration of different titanium dioxide nanoparticles in rats |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4105399/ https://www.ncbi.nlm.nih.gov/pubmed/24993397 http://dx.doi.org/10.1186/1743-8977-11-30 |
work_keys_str_mv | AT geraetsliesbeth tissuedistributionandeliminationafteroralandintravenousadministrationofdifferenttitaniumdioxidenanoparticlesinrats AT oomenagnesg tissuedistributionandeliminationafteroralandintravenousadministrationofdifferenttitaniumdioxidenanoparticlesinrats AT krystekpetra tissuedistributionandeliminationafteroralandintravenousadministrationofdifferenttitaniumdioxidenanoparticlesinrats AT jacobsennicklasr tissuedistributionandeliminationafteroralandintravenousadministrationofdifferenttitaniumdioxidenanoparticlesinrats AT wallinhakan tissuedistributionandeliminationafteroralandintravenousadministrationofdifferenttitaniumdioxidenanoparticlesinrats AT laurentiemichel tissuedistributionandeliminationafteroralandintravenousadministrationofdifferenttitaniumdioxidenanoparticlesinrats AT verharenhennyw tissuedistributionandeliminationafteroralandintravenousadministrationofdifferenttitaniumdioxidenanoparticlesinrats AT brandonestherfa tissuedistributionandeliminationafteroralandintravenousadministrationofdifferenttitaniumdioxidenanoparticlesinrats AT dejongwimh tissuedistributionandeliminationafteroralandintravenousadministrationofdifferenttitaniumdioxidenanoparticlesinrats |